| Internalization of exosomes through receptor-mediated endocytosis A Gonda, J Kabagwira, GN Senthil, NR Wall Molecular Cancer Research 17 (2), 337-347, 2019 | 236 | 2019 |
| Exosomal survivin facilitates vesicle internalization A Gonda, J Kabagwira, GN Senthil, HRF Bennit, JW Neidigh, S Khan, ... Oncotarget 9 (79), 34919, 2018 | 21 | 2018 |
| A practical approach to extracellular vesicle characterization among similar biological samples R de Necochea-Campion, A Gonda, J Kabagwira, S Mirshahidi, H Cao, ... Biomedical Physics & Engineering Express 4 (6), 065013, 2018 | 20 | 2018 |
| Natural killer cell phenotype and functionality affected by exposure to extracellular survivin and lymphoma-derived exosomes HR Ferguson Bennit, A Gonda, J Kabagwira, L Oppegard, D Chi, ... International Journal of Molecular Sciences 22 (3), 1255, 2021 | 18 | 2021 |
| Peripheral blood cell interactions of cancer-derived exosomes affect immune function HR Ferguson Bennit, A Gonda, JRW McMullen, J Kabagwira, NR Wall Cancer Microenvironment 12, 29-35, 2019 | 17 | 2019 |
| Cellular-defined microenvironmental internalization of exosomes A Gonda, R Moyron, J Kabagwira, PA Vallejos, NR Wall Extracellular vesicles and their importance in human health 10, 2019 | 16 | 2019 |
| Plasma exosome gene signature differentiates colon cancer from healthy controls PA Vallejos, A Gonda, J Yu, BG Sullivan, A Ostowari, ML Kwong, A Choi, ... Annals of surgical oncology 30 (6), 3833-3844, 2023 | 7 | 2023 |
| Optimization of blood handling for plasma extracellular vesicle isolation J Kabagwira, A Gonda, P Vallejos, B Babcock, WHR Langridge, M Senthil, ... Journal of Nanoparticle Research 23, 1-11, 2021 | 7 | 2021 |
| Internalization of exosomes through receptor-mediated endocytosis NR Wall, A Gonda, J Kabagwira, GN Senthil Mol. Cancer Res, 2018 | 5 | 2018 |
| An argument to examine exosomal survivin splice variant expression and patient survival in pancreatic cancer J Kabagwira, NR Wall Clin Oncol 2, 1-10, 2017 | 3 | 2017 |
| Exosomal proteins as a source of biomarkers in colon cancer‐derived peritoneal carcinomatosis–A pilot study PA Vallejos, RN Fuller, J Kabagwira, ML Kwong, A Gonda, ... PROTEOMICS–Clinical Applications 17 (2), 2100085, 2023 | 2 | 2023 |
| Survivin splice variant 2β enhances pancreatic ductal adenocarcinoma resistance to gemcitabine RN Fuller, J Kabagwira, PA Vallejos, AD Folkerts, NR Wall OncoTargets and Therapy 15, 1147, 2022 | 2 | 2022 |
| Amplifying Curcumin’s Antitumor Potential: A Heat-Driven Approach for Colorectal Cancer Treatment J Kabagwira, RN Fuller, PA Vallejos, CS Sugiono, VM Andrianarijaona, ... OncoTargets and Therapy, 63-78, 2024 | | 2024 |
| miRNA signatures underlie chemoresistance in the gemcitabine-resistant pancreatic ductal adenocarcinoma cell line MIA PaCa-2 GR RN Fuller, PA Vallejos, J Kabagwira, T Liu, C Wang, NR Wall Frontiers in Genetics 15, 1393353, 2024 | | 2024 |
| ASO Visual Abstract: Plasma Exosome Gene Signature Differentiates Colon Cancer from Healthy Controls PA Vallejos, A Gonda, J Yu, BG Sullivan, A Ostowari, ML Kwong, A Choi, ... Annals of surgical oncology 30 (6), 3847-3848, 2023 | | 2023 |
| The Role of Survivin Splice Variants in Pancreatic Ductal Adenocarcinoma Chemoresistance J Kabagwira Loma Linda University, 2021 | | 2021 |
| Exosomal Let 7 and its downstream protein targets may serve as predictive biomarkers in peritoneal carcinomatosis MLM Kwong, PA Vallejos, VM Andrianarijaona, A Choi, MJ Selleck, T Liu, ... Cancer Research 80 (16_Supplement), 6452-6452, 2020 | | 2020 |
| Liquid biopsy in colon cancer utilizing exosomal miRNA biomarkers: An initial analysis AH Choi, PA Vallejos, MLM Kwong, J Kabagwira, MJ Selleck, NR Wall, ... Cancer Research 80 (16_Supplement), 6446-6446, 2020 | | 2020 |
| Hyperthermic conditions improve curcumin efficacy for the treatment of peritoneal carcinomatosis of colon cancer origin J Kabagwira, PA Vallejos, AH Choi, C Sugiono, VM Andrianarijaona, ... Cancer Research 80 (16_Supplement), 1451-1451, 2020 | | 2020 |
| The role of survivin splice variants in pancreatic ductal adenocarcinoma Gemcitabine resistance J Kabagwira, A Gonda, ML Kwong, NR Wall Cancer Research 79 (13 Supplement), 3021-3021, 2019 | | 2019 |
